Friday, May 30, 2025

Latest

Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq Listing Requirements

In a classic Canadian small cap move, Mind Medicine (NEO: MMED) last night announced that it’s directors have approved a share consolidation. The consolidation follows an announcement in May that the company would be conducting an at-the-market financing to the tune of $100 million.

The reverse split will see the company reduce its share count on a 15 to 1 basis, resulting in an estimated 28.4 million shares outstanding on a post-consolidation basis. The figure implies the company has approximately 426 million shares outstanding currently, an increase from the 422.4 million outstanding as of March 31.

No fractional shares are to be issued with the consolidation, with such shares to be rounded off to the nearest whole number.

The consolidation is being conducted as a means of meeting Nasdaq minimum pricing requirements, as well as to provide the company with “greater flexibility in considering and planning for future potential business needs.”

The reverse split is expected to take effect after the close of markets on August 26, 2022.

Mind Medicine last traded at $0.91 on the Neo.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

First Majestic Makes Second Major Discovery At Santa Elena In Just A Year

Related News

MindMed Expects Results For Anxiety, ADHD Trials By Late 2023

It seems it is business as usual for Mind Medicine, aka MindMed, (NASDAQ: MNMD) as...

Monday, January 9, 2023, 10:40:35 AM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM

MindMed Adds MDMA To R&D Pipeline

Mind Medicine, also known as MindMed (NEO: MMED) this morning announced that it is branching...

Wednesday, May 27, 2020, 09:00:04 AM

MindMed Acquires HealthMode For $41.6 Million

MindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in...

Thursday, February 18, 2021, 08:21:32 AM

MindMed Begins Study On LSD Neutralizer Technology

MindMed (NEO: MMED) this morning announced that it has begun a study on what it...

Wednesday, February 17, 2021, 08:18:59 AM